Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria

Brain Res. 2002 Mar 29;931(2):117-25. doi: 10.1016/s0006-8993(02)02256-4.

Abstract

Accumulating data suggest a central role for mitochondria and oxidative stress in neurodegenerative apoptosis. We previously demonstrated that amyloid-beta peptide 25-35 (Abeta 25-35) toxicity in cultured cells is mediated by its effects on functioning mitochondria. In this study, we further explored the hypothesis that Abeta 25-35 might induce apoptotic cell death by altering mitochondrial physiology. Mitochondria in Ntera2 (NT2 rho+) human teratocarcinoma cells exposed to either staurosporine (STS) or Abeta 25-35 were found to release cytochrome c, with subsequent activation of caspases 9 and 3. However, NT2 cells depleted of mitochondrial DNA (rho0 cells), which maintain a normal mitochondrial membrane potential (Deltapsi(m)) despite the absence of a functional electron transport chain (ETC), demonstrated cytochrome c release and caspase activation only with STS. We further observed increased reactive oxygen species (ROS) production and decreased reduced glutathione (GSH) levels in rho+ and rho0 cells treated with STS, but only in rho+ cells treated with Abeta 25-35. We conclude that under in vitro conditions, Abeta can induce oxidative stress and apoptosis only when a functional mitochondrial ETC is present.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amyloid beta-Peptides / pharmacology*
  • Apoptosis / physiology*
  • Caspase 3
  • Caspase 9
  • Caspases / metabolism
  • Cell Death / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Cytochrome c Group / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Glutathione / metabolism
  • Humans
  • Intracellular Membranes / drug effects
  • Membrane Potentials / drug effects
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Oxidative Stress
  • Peptide Fragments / pharmacology*
  • Reactive Oxygen Species / metabolism
  • Staurosporine / pharmacology
  • Teratocarcinoma / drug therapy
  • Teratocarcinoma / metabolism*
  • Teratocarcinoma / pathology
  • Tumor Cells, Cultured

Substances

  • Amyloid beta-Peptides
  • Cytochrome c Group
  • Enzyme Inhibitors
  • Peptide Fragments
  • Reactive Oxygen Species
  • amyloid beta-protein (25-35)
  • CASP3 protein, human
  • CASP9 protein, human
  • Caspase 3
  • Caspase 9
  • Caspases
  • Glutathione
  • Staurosporine